Plain-English translation of NCT06468319 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — a large, organized tracking system — designed to gather health information from pregnant women and their babies in Kalifabougou, Mali. Researchers want to understand how many women get pregnant, what health challenges they face during and after pregnancy, and how malaria affects them. This information will help researchers design future studies testing new ways to prevent malaria in pregnant women, including monoclonal antibodies (mAbs), which are lab-made proteins that can fight disease.
Malaria during pregnancy is a serious health problem in Mali that can harm both the mother and the baby. Before researchers can test new treatments to prevent malaria in pregnant women, they need detailed information about pregnancy rates, outcomes, and how malaria currently affects mothers and infants in this community. This registry collects that foundational data.
You likely qualify if…
You likely don't qualify if…
If you join, you may first be identified and followed in your community for up to 3 years to detect if you become pregnant. Once pregnant, you would transition to the health facility part of the study, attending regular antenatal care visits at the health center. Researchers will collect information about your pregnancy, any complications, malaria infections, and your baby's health. After birth, you and your baby will be followed for up to 12 months to track health outcomes. The study involves routine check-ups, health questions, and possibly blood tests to check for malaria — care you would likely receive anyway.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Mali
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
National Institutes of Health (NIH), University of Washington
Enrollment target
~9,500 participants
Started
August 2024
Primary completion
June 2030
Age range
15 Years – 49 Years
Sex
Female only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kassoum Kayentao, MD, MPH, PhD
Faculté de Médecine Pharmacie d'Odontostomatologie (FMOS)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.